Citigroup Inc Seer, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Seer, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,150,090 shares of SEER stock, worth $2.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,150,090

Previous 1,290,152 10.86%

Holding current value

$2.6 Million

Previous $2.17 Million 4.01%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.59 - $2.07 $222,698 - $289,928	-140,062 Reduced 10.86%	1,150,090 $2.25 Million
Q2 2024 Aug 12, 2024	BUY	$1.65 - $2.24 $47,754 - $64,830	28,942 Added 2.29%	1,290,152 $2.17 Million
Q1 2024 May 10, 2024	BUY	$1.54 - $2.09 $1.88 Million - $2.55 Million	1,219,061 Added 2892.27%	1,261,210 $2.4 Million
Q4 2023 Feb 09, 2024	BUY	$1.47 - $2.22 $61,913 - $93,501	42,118 Added 135864.52%	42,149 $81,000
Q3 2023 Nov 09, 2023	SELL	$2.18 - $5.52 $37,997 - $96,213	-17,430 Reduced 99.82%	31 $0
Q2 2023 Aug 10, 2023	BUY	$3.16 - $4.96 $51,204 - $80,371	16,204 Added 1289.1%	17,461 $74,000
Q1 2023 May 11, 2023	SELL	$3.6 - $5.88 $1,638 - $2,675	-455 Reduced 26.58%	1,257 $4,000
Q4 2022 Feb 09, 2023	SELL	$5.03 - $8.58 $5,477 - $9,343	-1,089 Reduced 38.88%	1,712 $9,000
Q3 2022 Nov 10, 2022	SELL	$7.7 - $13.31 $23,408 - $40,462	-3,040 Reduced 52.05%	2,801 $22,000
Q2 2022 Aug 10, 2022	BUY	$6.72 - $16.07 $10,180 - $24,346	1,515 Added 35.02%	5,841 $52,000
Q1 2022 May 12, 2022	SELL	$11.88 - $23.4 $103,653 - $204,165	-8,725 Reduced 66.85%	4,326 $66,000
Q4 2021 Feb 10, 2022	BUY	$21.08 - $38.51 $143,660 - $262,445	6,815 Added 109.28%	13,051 $298,000
Q3 2021 Nov 10, 2021	BUY	$27.67 - $45.04 $172,550 - $280,869	6,236 New	6,236 $215,000

Others Institutions Holding SEER

# of Institutions

Shares Held

35.2M

Call Options Held

Put Options Held

600

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $132M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account